Choosing the right cell line is a critical part of biopharmaceutical process development. Getting it wrong can delay scaleup and hurt a drug’s commercial potential. The key to success is full ...
Advances in cell line engineering and microfluidic technologies offer substantial opportunities to shorten timelines in cell line development (CLD). However, as with any innovation, optimizing these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results